Neurocrine Bioscience buy Wells Fargo & Company
Start price
16:30
/
50%
€149.30
Target price
17.07.27
€174.84
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 17.07.27. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | - |
| iShares Core DAX® | -1.087% |
| iShares Nasdaq 100 | -2.463% |
| iShares Nikkei 225® | -5.371% |
| iShares S&P 500 | -0.197% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Wells Fargo & Company from $175.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.55
13.02.26
13.02.26
€147.44
13.02.27
13.02.27
41.45%
16:03
16:03
